Medicamen Biotech Limited — Board Meeting, 11-02-2025: Outcome of Board Meeting

The Board has approved the unaudited financial results for the quarter and nine months ended December 31, 2024, which will be available on the company's website. Additionally, Mr. Chandan Kumar has been appointed as Chief Financial Officer and Key Managerial Personnel of the company. His extensive experience in accounting, taxation, and auditing spans over 15 years, including prior roles in various leading firms. These decisions reflect the company's ongoing focus on strengthening its financial leadership and operational transparency.